Cargando…
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up
INTRODUCTION: At present, there is no reliable tool for predicting disease outcome in patients with rheumatoid arthritis (RA). We previously demonstrated an association between specific baseline biomarkers/clinical measures including matrix metalloproteinase-3 (MMP-3) and 2-year radiographic progres...
Autores principales: | Houseman, Mark, Potter, Catherine, Marshall, Nicola, Lakey, Rachel, Cawston, Tim, Griffiths, Ian, Young-Min, Steven, Isaacs, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392825/ https://www.ncbi.nlm.nih.gov/pubmed/22314025 http://dx.doi.org/10.1186/ar3734 |
Ejemplares similares
-
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis
por: Dörr, Sylvia, et al.
Publicado: (2004) -
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
por: Smolen, Josef S., et al.
Publicado: (2020) -
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
por: Mewar, Devesh, et al.
Publicado: (2006) -
Which patients with rheumatoid arthritis are still working?
por: Uhlig, Till
Publicado: (2010) -
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
por: Landewé, Robert B. M., et al.
Publicado: (2016)